18
M. Suzuki et al. / Phytochemistry 75 (2012) 14–20
7.26, dC 77.0). Mass spectra were obtained with a JEOL AX-505
spectrometer. Optical rotations were determined with a Horiba
SEPA-200 high sensitive polarimeter. A Shimadzu LC-6A liquid
chromatography system was used for HPLC analysis. In the precur-
sor administration experiment and the enzyme assay for the con-
version of deoxyradicinin (1) to radicinin (3), HPLC was
performed using a DAISOPAK SP-120-5-ODS-AP column (DAISO
Co., Ltd., 150 ꢁ 6 mm), MeOH–H2O–AcOH (100:99:1, v/v/v) as
solvent at a flow rate of 0.5 ml/min, monitoring at 280 nm. In the
enzyme assay for the conversion of radicinin (3) to 3-epi-radicinin
(4), HPLC was carried out using a DAISOPAK SP-250-10-ODS-AP
column (DAISO Co., Ltd., 250 ꢁ 10 mm), MeOH–H2O–AcOH
(100:99:1, v/v/v) as solvent at a flow rate of 0.5 ml/min, and mon-
itoring at 280 nm. Silica gel flash column chromatography (CC) was
carried out by use of Wakogel FC-40 (Wako Pure Chemical Indus-
tries, Ltd.). Protein concentrations were determined with Bradford
reagent (Sigma–Aldrich) using BSA as a standard.
4.4.2. 4-Methoxy-6-[(E)-1-propenyl]-2H-pyran-2-one (9)
Ethyltriphenylphosphonium bromide (1.2 g, Wako Pure Chemi-
cal Industries, Ltd.) was dissolved into DMF (11 ml), and then
bis(trimethylsilyl) amide (3 ml, Sigma–Aldrich, Inc.) was added.
Compound 8 (120 mg) in DMF (4 ml) was added and the mixture
was stirred vigorously at r.t. for 3 h under N2. The reaction mixture
was poured into brine (70 ml) and extracted with EtOAc
(70 ml ꢁ 3). The combined EtOAc solubles were dried (Na2SO4)
and evaporated in vacuum to dryness. The residue was subjected
to Si gel flash CC (150 ꢁ 20 mm), which was developed succes-
sively with 200 ml each of Me2CO–n-hexane (5:95,1:9,2:8 and
3:7,v/v), respectively. Compound 9 and its Z-isomer were eluted
with Me2CO–n-hexane (1:9 and 1:4, v/v) fractions (61 mg). Heating
of the crystalline mixture at 130 °C in a sealed tube under N2
caused isomerization to give 57 mg of compound 9: dH 6.68 (1H,
dq, J = 15.5, 7.0 Hz, 8-H) 5.97 (1H, dq, J = 15.5, 1.5 Hz, 7-H), 5.74
(1H, d, J = 2.2 Hz, 5-H), 5.43 (1H, d, J = 2.2 Hz, 3-H), 3.80 (3H, s,
10-H), 1.88 (3H, dd, J = 7.0, 1.5 Hz, 9-H); EI-MS, 70 eV, m/z 166
(M+, 63%), 138 (100), and 69 (38).
4.2. Fungal strain
The strain H13-3 of B. coicis was used in the experiments (Nak-
ajima et al., 1997). B. coicis H13-3 was maintained on potato dex-
trose agar slants.
4.4.3. 3-[(E)-2-butenoyl]-4-methoxy-6-[(E)-1-propenyl]-2H-pyran-2-
one (10)
To a mixture of compound 9 (80 mg) and TiCl4 (260
Pure Chemical Industries, Ltd.) in CH2Cl2 (1 ml), crotonoyl chloride
(70 l, Wako Pure Chemical Industries, Ltd.) was added slowly. The
ll, Wako
4.3. Isolation of radicinin
l
solution was stirred at r.t. for 20 min, and then at 45 °C for 6 h. It
was then poured into brine (30 ml), and extracted with EtOAc
(30 ml x 3). The EtOAc solubles were combined, dried over Na2SO4,
and evaporated to dryness. The resulting residue was purified by Si
gel flash CC (150 ꢁ 20 mm) developed successively with 100 ml
each of Me2CO in n-hexane (1:4,1:3,3:7 and 35:65 v/v). Compound
10 (40 mg) was eluted with Me2CO–n-hexane (1:4, v/v) whereas
compounds 1 and 2 were eluted using Me2CO–n-hexane (3:7, v/
v). Separation of compounds 1 and 2 by chiral HPLC used a CHIR-
ALPAK OD column (Daicel Chemical Industries, Ltd.,
4.6 ꢁ 250 mm), eluted with EtOH-n-hexane (1:1, v/v) at a flow rate
of 0.5 ml/min, and monitoring at 280 nm to afford compounds 1
(2.5 mg) and 2 (3.0 mg). The retention times of compounds 1 and
2 were 26.2 and 30.8 min, respectively. Compound 10: dH 1.85
(3H, dd, J = 7.0, 1.4 Hz, 9-H), 1.87 (3H, dd, J = 7.0, 1.4 Hz, 140-H),
3.82 (3H, s, 10-H), 5.94 (1H, s, 5-H), 5.97 (1H, dq, J = 15.5, 1.4 Hz,
7-H), 6.40 (1H, dq, J = 15.5, 1.4 Hz, 12-H), 6.82 (2H, m, 8, 13-H);
EI-MS, 70 eV, m/z 234 (M+, 100%), 193 (80), 165 (48), and 138 (32).
The fungus was grown without shaking at 24 °C for 14 days in
the dark in a 500 ml conical flask containing liquid medium
(200 ml ꢁ 5) made up of glucose (30 g/l), peptone (3 g/l) and an ex-
tract from 50 g/l of malt and H2O. The culture filtrate was acidified
to pH 2.0 with HCl, and the metabolites in the culture filtrate were
extracted with EtOAc (500 ml ꢁ 3). The EtOAc extract was dried
over Na2SO4 and evaporated. The residue (270 mg) was applied
to
a silica gel column (Daisogel IR-60, DAISO, Co., Ltd.,
180 ꢁ 18 mm), and the column was washed with 1500 ml of
Me2CO–n-hexane (1:9,v/v), then developed successively with
750 ml each of Me2CO–n-hexane (2:8, 3:7 and 4:6, v/v). Fractions
3 and 4 eluted by Me2CO–n-hexane (3:7, v/v) were combined
and evaporated. Recrystallization of the residue (34 mg) from
MeOH afforded radicinin (3) as colorless needles (6 mg): dH 6.93
(1H, dq, J = 15.5, 7.0 Hz, 20-H), 6.02 (1H, dq, J = 15.5, 1.7 Hz, 10-H),
5.83 (1H, s, 8-H), 4.36 (1H, dq, J = 12.4, 6.0 Hz, 2-H), 3.97 (1H, d,
J = 12.4 Hz, 3-H), 1.96 (3H, dd, J = 7.0, 1.7 Hz, 3’-H), 1.64 (3H, d,
J = 6.0 Hz, 2-Me); dC (CDCl3) 188.7, 176.0, 164.4, 156.8, 141.0,
122.6, 98.1, 97.2, 80.0, 72.0, 18.8, 18.1, CI-MS (iso-butane, probe),
200 eV, m/z 237 ([M+H]+, 100%).
4.4.4. Deoxyradicinin (1)
A mixture of compound 10 (40 mg), TiCl4 (90 ll) and CH2Cl2
(1 ml) was stirred at 45 °C for 3 h. It was then poured into brine
(30 ml), extracted with EtOAc (30 ml ꢁ 3). The organic layer was
washed with brine (100 ml ꢁ 3). The combined EtOAc extracts
were dried (Na2SO4) and evaporated to dryness, with the residue
was subjected to Si gel flash CC (150 ꢁ 20 mm) developed succes-
sively with 100 ml each of Me2CO-n-hexane (1:4,1:3,3:7 and
35:65,v/v). Compounds 1 and 2 were eluted with Me2CO-n-hexane
(3:7, v/v), and separated by chiral HPLC as above to afford com-
pounds 1 (1.8 mg) and 2 (2.5 mg). Compound 1, 2: dH 6.86 (1H,
m, 20-H), 5.95 (1H, dq, J = 15.5, 1.8 Hz, 10-H), 5.76 (1H, s, 8-H),
4.67 (1H, m, 2-H), 2.59 (2H, m, 3–H), 1.88 (3H, dd, J = 7.3, 1.4 Hz,
30-H), 1.46 (3H, d, J = 5.6 Hz, 2-Me); dC 186.2, 176.6, 163.8, 156.7,
138.9, 124.0, 100.7, 99.1, 77.6, 44.3, 20.4, 18.6; EI-MS, 70 eV, m/z
4.4. Synthesis of deoxyradicinin
4.4.1. 6-Formyl-4-methoxy-2H-pyran-2-one (8)
The mixture of 4-methoxy-6-methyl-2H-pyran-2-one (7;
500 mg, Sigma–Aldrich, Inc.), SeO2 (1.2 g, Kanto Chemical Co.,
Inc.) and anhydrous dioxane (5 ml) in a sealed tube was heated
at 160 °C (outside) and stirred vigorously. After 3 h, the precipitate
was removed by filtration and washed with dioxane. The latter was
removed by evaporation in vacuo to afford a residue, which was
poured into brine (100 ml). The resulting product was extracted
with EtOAc (100 ml ꢁ 3) with the EtOAc solubles combined. After
drying over Na2SO4, the extract was evaporated to dryness. The
residue was purified by Si gel flash CC. The column
(150 ꢁ 20 mm) was developed successively with 300 ml of
Me2CO–n-hexane (3:7, 4:6 and 1:1 v/v), respectively. Compound
8 (362 mg) was eluted with Me2CO–n-hexane (4:6, v/v): dH 9.48
(1H, s, 7-H), 6.63 (1H, d, J = 2.3 Hz, 5-H), 5.70 (1H, d, J = 2.3 Hz, 3-
H), 3.82 (3H, s, 8-H); EI-MS, 70 eV, m/z 154 (M+, 22%), 125 (100),
69 (20), and 59 (15).
220 (M+, 100%), 205 (50), and 177 (59). Compound 1: [
0.1, CHCl3). Compound 2: [
ꢀ82° (c 0.1, CHCl3).
a] +90°(c
D
a]
D
4.5. Precursor administration
The fungus was grown on medium (500
malt extract broth (Difco Laboratories Inc.) in
l
l) containing 15 g/l of
test tube
a